MétaCan
Menu
Back to cohort
Record W4409118900 · doi:10.1111/trf.18236

Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda

2025· article· en· W4409118900 on OpenAlexaff
Tait Huso, Jodie L. White, Dorothy Kyeyune, Angela D’Adamo, Nazzarena Labò, Wendell Miley, Ezra Musisi, Khan Moses, Ronnie Kasirye, Irene Lubega, Hellen Musana, Priscilla Eroju, Mahnaz Motevalli, Raymond P. Goodrich, M. Kate Grabowski, Thomas C. Quinn, Paul M. Ness, Heather Hume, Henry Ddungu, Aggrey Dhabangi, Evan M. Bloch, Mary Glenn Fowler, Philippa Musoke, Denise Whitby, Aaron A.R. Tobian

Bibliographic record

VenueTransfusion · 2025
Typearticle
Languageen
FieldMedicine
TopicViral-associated cancers and disorders
Canadian institutionsUniversité de Montréal
FundersNHLBI Division of Intramural ResearchNational Cancer InstituteNational Institute of Diabetes and Digestive and Kidney DiseasesU.S. Department of DefenseNational Heart, Lung, and Blood InstituteFrederick National Laboratory for Cancer ResearchDivision of Intramural Research, National Institute of Allergy and Infectious Diseases
KeywordsSeroprevalenceMedicineVirologyPopulationImmunologyTransmission (telecommunications)Confidence intervalBlood transfusionKaposi's sarcoma-associated herpesvirusAntigenAntibodyViral diseaseVirusInternal medicineHerpesviridaeSerologyEnvironmental health

Abstract

fetched live from OpenAlex

BACKGROUND: Kaposi's sarcoma herpesvirus (KSHV) causes a life-long infection that can progress to several types of KSHV-associated diseases. There is evidence for transfusion transmission of KSHV. In endemic regions, such as sub-Saharan African, KSHV seroprevalence is >40%. However, previous studies of blood donors utilized immunoassays that detect KSHV-associated disease-specific antigens, which may underestimate the true burden of KSHV in a healthy population. STUDY DESIGN AND METHODS: We utilized samples from an on-going transfusion transmitted infection clinical trial to estimate the seroprevalence of KSHV among 4921 blood donations from healthy donors in Uganda collected between October 2019 and December 2022. A multiplexed bead-based assay was used to measure plasma IgG against five antigens encoded by the K8.1, K10.5, ORF73, ORF38, and ORF25 genes of KSHV. Significant associations between donor characteristics and seroprevalence were assessed by chi-square tests. RESULTS: Overall, KSHV seroprevalence was 69.1%. Seroprevalence was higher in units collected from older donors compared with younger donors and male donors (71.9% [95% confidence interval (CI) = 70.4%-73.3%]) compared with female donors (61.3% [95% CI = 58.6%-64.0%]; p < .001). KSHV seroprevalnce was higher among units collected from donors positive for T. pallidum (82.5% [95% CI = 73.8%-89.3%]) compared with units collected from donors who were negative (68.8% [95% CI = 67.5%-70.1%]; p < .001). KSHV seroprevalence was higher in units that tested positive for HIV, HBV, or HCV, though these results were not statistically significant. CONCLUSION: Given the high seroprevalence and limited availability of lab assays that detect active KSHV infections, methods such as leukoreduction or pathogen reduction should be considered to potentially reduce the risk of transfusion transmission of KSHV.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.254
Teacher spread0.247 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueTransfusionSame topicViral-associated cancers and disordersFrench-language works237,207